124 related articles for article (PubMed ID: 7448129)
1. Impaired thromboxane production by newly formed platelets after aspirin administration to thrombocytopenic rats.
Dejana E; Barbieri B; Cerletti C; Livio M; de Gaetano G
Br J Haematol; 1980 Nov; 46(3):465-9. PubMed ID: 7448129
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane production in the pregnant rat: differential recovery by platelets and uterus following aspirin administration.
Dubin NH; Ghodgaonkar RB; Blake DA
Biol Reprod; 1983 Oct; 29(3):743-9. PubMed ID: 6626652
[TBL] [Abstract][Full Text] [Related]
3. Aspirin inhibits rat megakaryocyte thromboxane synthesis.
Worthington RE; Nakeff A
Prostaglandins; 1982 Jun; 23(6):841-53. PubMed ID: 6812167
[TBL] [Abstract][Full Text] [Related]
4. The biological significance of platelet volume: its relationship to bleeding time, platelet thromboxane B2 production and megakaryocyte nuclear DNA concentration.
Martin JF; Trowbridge EA; Salmon G; Plumb J
Thromb Res; 1983 Dec; 32(5):443-60. PubMed ID: 6658722
[TBL] [Abstract][Full Text] [Related]
5. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin.
Packham MA; Guccione MA; O'Brien KM
Blood; 1985 Aug; 66(2):287-90. PubMed ID: 3926022
[TBL] [Abstract][Full Text] [Related]
6. Recovery of megakaryocyte thromboxane production in vitro after aspirin inhibition.
Walenga RW; Miller JL; Stuart MJ
Biochem Biophys Res Commun; 1984 Mar; 119(3):982-8. PubMed ID: 6712680
[TBL] [Abstract][Full Text] [Related]
7. Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.
DeRubertis FR; Craven PA
Metabolism; 1992 Jan; 41(1):90-6. PubMed ID: 1538647
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the production of thromboxane B2 and malondialdehyde by human blood platelets.
Best LC; Jones PB; Russell RG
Clin Sci (Lond); 1980 Aug; 59(2):131-5. PubMed ID: 7190885
[No Abstract] [Full Text] [Related]
9. Inhibition of platelet thromboxane generation by suloctidil in man.
Bucchi F; Cerletti C; de Gaetano G
Haemostasis; 1986; 16(5):362-8. PubMed ID: 3023210
[TBL] [Abstract][Full Text] [Related]
10. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs.
Reilly IA; FitzGerald GA
Blood; 1987 Jan; 69(1):180-6. PubMed ID: 3790723
[TBL] [Abstract][Full Text] [Related]
12. The source of thromboxane and prostaglandins in experimental inflammation.
Higgs GA; Moncada S; Salmon JA; Seager K
Br J Pharmacol; 1983 Aug; 79(4):863-8. PubMed ID: 6652359
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment: dependence on the dose of the aggregating agent.
De Caterina R; Giannessi D; Gazzetti P; Bernini W
Thromb Res; 1985 Jan; 37(2):337-42. PubMed ID: 3975876
[No Abstract] [Full Text] [Related]
14. Aspirin does not inhibit human megakaryocyte thromboxane synthesis in vivo.
Huijgens PC; van den Berg CA; Imandt LM; Miltenburg A; Langenhuijsen MM
Scand J Haematol; 1986 Jan; 36(1):92-5. PubMed ID: 3081996
[TBL] [Abstract][Full Text] [Related]
15. Platelet malondialdehyde production kinetics after cyclooxygenase block. A study performed with a modified high sensitivity assay.
Nenci GG; Parise P; Capodicasa E; Berrettini M
Haemostasis; 1983; 13(1):53-60. PubMed ID: 6404715
[TBL] [Abstract][Full Text] [Related]
16. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
[TBL] [Abstract][Full Text] [Related]
17. Thromboxane generation in patients with essential hypertension or cerebrovascular disease and effect of oral aspirin.
Matsumoto M; Nukada T; Uyama O; Yoneda S; Imaizumi M; Miyamoto T; Kayama N
Thromb Haemost; 1980 Aug; 44(1):16-22. PubMed ID: 7423441
[TBL] [Abstract][Full Text] [Related]
18. A study of the bioavailability and platelet inhibitory effects of a new enteric-coated acetylsalicylic acid preparation.
Kelton JG; Carter CJ; Rosenfeld J; Nguyen KB
Thromb Res; 1984 Jun; 34(6):561-6. PubMed ID: 6740573
[No Abstract] [Full Text] [Related]
19. Inhibition of prostacyclin and platelet thromboxane A2 after low-dose aspirin.
Preston FE; Whipps S; Jackson CA; French AJ; Wyld PJ; Stoddard CJ
N Engl J Med; 1981 Jan; 304(2):76-9. PubMed ID: 7003384
[TBL] [Abstract][Full Text] [Related]
20. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
Preston FE; Greaves M; Jackson CA; Stoddard CJ
Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
